GGrantIndex
Sort

40,608 grants matching prostate cancer

New Therapies to Restore Vascular Integrity During Sepsis

$733,546
Andrew Scott Weyrich · University Of Utah · R01 · FY2017 · HL

Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States

$733,285
Xuehong Zhang · Yale University · U01 · FY2025 · CA

Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients

$733,228
Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA

Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent

$733,096
Seth J Field · Case Western Reserve University · R01 · FY2021 · CA

MOUSE MODELS FOR HUMAN PROSTATE CANCER

$732,995
University Of California Los Angeles · U01 · FY2002 · CA

Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data

$732,586
Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2021 · CA

(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities

$732,446
Margaret M Whalen · Tennessee State University · U54 · FY2021 · CA

AKT as a Biomarker of Ovarian Cancer Progression and a Target for Therapy

$732,444
Joseph Robert Testa · Fox Chase Cancer Center · P50 · FY2007 · CA

Genetic Aspects Of Viral Oncogenesis In Wild Mouse Species

$732,400
Christine Kozak · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Illinois Oncology Research Association Community Clinical Oncology Program

$732,293
Nguyet A. Le-Lindqwister · Oncology-Hematology Assoc-Central Ill · U10 · FY2011 · CA

Instrumentation Development and Engineering Application Solutions (IDEAS) Shared Resource

$732,263
Thomas Pohida · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2024 · EB

High Performance Digital Medical Data Link Technology

$732,094
Physical Optics Corporation · R44 · FY2003 · LM

Mechanisms of Normal Tissue Toxicity

$731,927
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Exploring PSMA Biology in Tumor neovasculature

$731,830
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Exploring PSMA Biology in Tumor neovasculature

$731,830
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Enabling Technologies for MRI-Guided Prostate Interventions

$731,599
Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2008 · CA

Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care

$731,415
Tina Hernandez-Boussard · Stanford University · R01 · FY2017 · CA

Role of Neurotrophins in the Development of the Mammalian Nervous System

$731,359
Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

New Therapies to Restore Vascular Integrity During Sepsis

$731,125
Andrew Scott Weyrich · University Of Utah · R01 · FY2016 · HL

A Randomized Hybrid Type I effectiveness-implementation study of an Ehealth delivery Alternative for Cancer genetic testing for Hereditary cancer predisposition (eREACH)

$731,103
Angela R. Bradbury · University Of Pennsylvania · U01 · FY2024 · CA

(PQC4) Habitats in Prostate Cancer

$730,977
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA

SAN ANTONIO CENTER OF BIOMARKERS OF RISK FOR PROSTATE CA

$730,578
University Of Texas Hlth Sci Ctr San Ant · U01 · FY2001 · CA

Chemistry and Biology of Platinum Anticancer Drugs

$730,539
Stephen J Lippard · Massachusetts Institute Of Technology · R01 · FY2009 · CA

CHARACTERIZING THE AGGRESSIVENESS OF PROSTATE CANCER WITH MULTIMODALITY IMAGING

$730,536
University Of Western Ontario · · FY2019 · Defense Health Agency

CANCER CENTER SUPPORT GRANT

$730,469
Wayne State University · P30 · FY2003 · CA